======= MINA ======= == Gene Information == * **Official Symbol**: RIOX2 * **Official Name**: ribosomal oxygenase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84864|84864]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUF8|Q8IUF8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MINA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MINA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612049|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Oxygenase that can act as both a histone lysine demethylase and a ribosomal histidine hydroxylase. Is involved in the demethylation of trimethylated 'Lys-9' on histone H3 (H3K9me3), leading to an increase in ribosomal RNA expression. Also catalyzes the hydroxylation of 60S ribosomal protein L27a on 'His-39'. May play an important role in cell growth and survival. May be involved in ribosome biogenesis, most likely during the assembly process of pre-ribosomal particles. {ECO:0000269|PubMed:12091391, ECO:0000269|PubMed:14695334, ECO:0000269|PubMed:15534111, ECO:0000269|PubMed:15819408, ECO:0000269|PubMed:15897898, ECO:0000269|PubMed:17317935, ECO:0000269|PubMed:19502796, ECO:0000269|PubMed:23103944}. |Cupin 4| |dioxygenase activity| |transcription factor complex| |transcription corepressor activity| |ribosome biogenesis| |ribonucleoprotein complex biogenesis| |nucleolus| |oxidation-reduction process| |identical protein binding| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-2.02| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.7| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|1.72| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|1.85| |[[:results:exp136|MS094 2μM R03 exp136]]|1.89| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.35| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.411| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2682 * **Expression level (log2 read counts)**: 5.87 {{:chemogenomics:nalm6 dist.png?nolink |}}